PATHSTONE FAMILY OFFICE, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
PATHSTONE FAMILY OFFICE, LLC portfolio value:
$2.90M
portfolio value
PATHSTONE FAMILY OFFICE, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +116.28% | 2.24K shares | 1.76M | $688.87 | 4.17K |
| Q2 2022 | share | Increase | +73.32% | 816 shares | 339K | $591.13 | 1.92K |
| Q1 2022 | share | Increase | +8.27% | 85 shares | 153K | $698.42 | 1.11K |
| Q4 2021 | share | Increase | +115.97% | 552 shares | 361K | $642.51 | 1.02K |
| Q3 2021 | share | Decrease | -6.85% | -35 shares | 3K | $605.18 | 476 |
| Q2 2021 | share | Increase | +1.19% | 6 shares | 46K | $558.54 | 511 |
| Q1 2021 | share | Increase | +46.80% | 161 shares | 73K | $473.14 | 505 |
| Q4 2020 | share | Increase | +237.25% | 242 shares | 109K | $483.11 | 344 |
| Q3 2020 | share | 0.00% | 0 shares | -6K | $559.78 | 102 | |
| Q2 2020 | share | Decrease | -16.39% | -20 shares | 3K | $623.65 | 102 |
| Q1 2020 | share | Decrease | -11.59% | -16 shares | 59.48K | $488.29 | 122 |
| Q4 2019 | share | Increase | +38.00% | 38 shares | -27.48K | $375.48 | 138 |
| Q3 2019 | share | 0.00% | 0 shares | -3K | $277.4 | 100 | |
| Q2 2019 | share | Decrease | -17.36% | -21 shares | -19K | $313 | 100 |
| Q1 2019 | share | Increase | +476.19% | 100 shares | 42K | $410.62 | 121 |
| Q4 2018 | share | Increase | 0.00% | 21 shares | 8K | $373.5 | 21 |
| Q2 2017 | share | Decrease | -100.00% | -3 shares | -1K | $491.14 | 0 |
| Q1 2017 | share | Increase | 0.00% | 3 shares | 1K | $387.51 | 3 |